| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer | Chief Financial Officer
1 company
Poulton Jeffrey V. is an EVP, Chief Financial Officer at ALNYLAM PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $17.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2023 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Financial Officer | Sell | 3,460 | $185.85 | $643,036.64 | -3.3% | -13.0% | +46.6% | |
| Apr 27, 2023 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Financial Officer | Sell | 977 | $194.59 | $190,113.44 | -1.6% | -0.6% | -26.9% |